BioInvent (Sweden)

BioInvent (Sweden)

BioInvent International is a Swedish clinical-stage biotech company that discovers and develops novel and first-in-class immunomodulatory antibodies for cancer therapy. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for BioInvent (Sweden), Sweden, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

47%


Total
Publications

114


Total Open
Publications

54


Total
Citations

4.2K


Open Access
Percentage

47%


Total
Publications

114


Total Open
Publications

54


Total
Citations

4.2K

Wikipedia

Website

download

Breakdown

21% 24% 3% 52%

Publisher Open

21%

Both

24%

Other Platform Open

3%

Closed

52%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0123456789101112Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

53%OA Journal

OA Journal 53%

27

Hybrid 22%

11

No Guarantees 25%

13

Other Platform Open

Domain 87%

26

Institution 33%

10

Public 7%

2

Other Internet 7%

2

Preprint 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
26
University of Cambridge - Apollo
Institution
3
Figshare
Public
3
Europe PMC
Domain
2
DOI
Other Internet
2
ZB MED - Informationszentrum Lebenswissenschaften
Institution
1
University of Southern Denmark - University of Southern Denmark Research Portal
Institution
1
University of Leicester - Leicester Research Archive
Institution
1
University of Bath - Pure
Institution
1
Lund University - Lund University Publications
Institution
1
1 / 2

Data updated 18 August 2025

Share

Share

Share